Mary Chappell
Obstetrics & Gynecology · Marietta, GANPI 1336199462
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.8% of the total across 146 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 16.5% — the pattern of someone who eats at a lot of different presentations.
Across 146 payments — averaging $18.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$439
- Mayne Pharma Commercial LLC$429
- Coopersurgical, Inc.$234
- Astellas Pharma US Inc$174
- Exeltis, USA Inc.$155
- Organon$153
- plus $1K from 25 others
What the payments were for
- Food & beverage$2,62299%
- Education$321%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 25 | $439 |
| Mayne Pharma Commercial LLC | 22 | $429 |
| Coopersurgical, Inc. | 12 | $234 |
| Astellas Pharma US Inc | 9 | $174 |
| Exeltis, USA Inc. | 8 | $155 |
| Organon | 9 | $153 |
| Pfizer | 8 | $136 |
| Bayer | 6 | $106 |
| Therapeuticsmd, Inc. | 7 | $97 |
| Davol Inc. | 3 | $70 |
| Hologic Sales And Service, LLC | 4 | $68 |
| Evofem Biosciences, Inc. | 4 | $65 |
| Sumitomo Pharma America, Inc. | 4 | $63 |
| Revance Therapeutics, Inc. | 1 | $56 |
| Avion Pharmaceuticals | 3 | $37 |
| Optumhealth Care Solutions, LLC | 2 | $36 |
| Boston Scientific | 2 | $34 |
| Merck | 2 | $32 |
| Vertical Pharmaceuticals, LLC | 2 | $31 |
| AstraZeneca | 2 | $30 |
| Myovant Sciences Inc. | 1 | $29 |
| Biogen | 1 | $29 |
| Inari Medical, Inc. | 1 | $28 |
| Alydia Health | 1 | $20 |
| Agile Therapeutics, Inc. | 1 | $19 |
| Daiichi Sankyo Inc. | 1 | $17 |
| KCI USA, Inc. | 1 | $14 |
| AMAG Pharmaceuticals, Inc. | 1 | $14 |
| Ascend Therapeutics US, LLC | 1 | $14 |
| Conmed Corporation | 1 | $13 |
| Channel Medsystems, Inc. | 1 | $9 |
How this compares
$2,653 in reported general payments places this provider in the 75th percentile of 1,324 obstetrics & gynecology providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ValacyclovirValacyclovir Hcl | 12 | $1,124 |
| Estradiol | 13 | $703 |
| ProgesteroneProgesterone, Micronized | 11 | $235 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Marietta
- Teresa ByrdMarietta$41K
- Eduardo EstrellaMarietta$26K
- Jeffrey MarcusMarietta$12K
- Edmund KimLawrenceville$628K
- Jacquelin WaltersDuluth$147K
- Nicole SparksJohns Creek$121K
- Lethenia BakerThomaston$111K
- Renee AllenAtlanta$74K
- Matthew RalstenFayetteville$64K
- Murray FreedmanAugusta$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.